NCT06182176View on ClinicalTrials.gov

Effectiveness and Cost-effectiveness of Integrated Model for Malaria and Helminth Control

NANot yet recruitingINTERVENTIONAL

Enrollment

1,200

Participants

Timeline

Start Date

May 27, 2024

Primary Completion Date

November 29, 2024

Study Completion Date

January 12, 2026

Conditions

MalariaSoil Transmitted HelminthsSchistosomiasisSeasonal Malaria ChemopreventionMass Drug Administration With Anthelminthic Drugs

Interventions

DRUG

Sulphadoxine-pyrimethamine and Amodiaquine

The intervention drugs are standard drugs approved by the World Health Organisation for the preventive treatment of malaria (sulphadoxine-pyrimethamine and amodiaquine), schistosomiasis (praziquantel) and soil-transmitted helminths (albendazole).

All Listed Sponsors

collaborator

Kintampo Health Research Centre, Ghana

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT06182176 - Effectiveness and Cost-effectiveness of Integrated Model for Malaria and Helminth Control | Biotech Hunter | Biotech Hunter